Acquires of Minaris Regenerative Medicine by Altaris, a US healthcare fund (represented Altaris) Home Practices Acquires of Minaris Regenerative Medicine by Altaris, a US healthcare fund (represented Altaris) Period September, 2024 Practices M&A People Kenichi Sekiguchi Kenichi Sekiguchi Partner Tokyo +81-3-6266-8562 kenichi.sekiguchi@morihamada.com M&A Corporate Law Asset Management / Funds Dispute Resolution Yasutaka Tokuda Yasutaka Tokuda Partner Tokyo +81-3-6266-8934 yasutaka.tokuda@morihamada.com M&A Crisis Management / Compliance Life Science / Healthcare Consumer Law Public Policy Masaaki Hirota Masaaki Hirota Partner Tokyo +81-3-6266-8985 masaaki.hirota@morihamada.com M&A Structured Finance / Banking Fumiya Sunose Fumiya Sunose Senior Associate Tokyo +81-3-5223-7791 M&A Corporate Law Yurika Inoue Yurika Inoue Senior Associate Tokyo +81-3-6213-8163 M&A Life Science / Healthcare Intellectual Property Corporate Law Related Cases June 3, 2025 Case Highlights Privatization of Makino Milling Machine by MBK Partners (represented MBK Partners as a white knight) Shuhei Uchida Masaaki Hirota Kei Shirakawa Masaki Kakimoto June, 2025 Privatization of TRYT by Carlyle (represented TRYT) Masaaki Hirota Ryosuke Shigaki May 29, 2025 Case Highlights Privatization of SBI Sumishin Net Bank by NTT DOCOMO and capital and business alliance among Sumitomo Mitsui Trust Bank, NTT DOCOMO, and SBI Sumishin Net Bank (represented Sumitomo Mitsui Trust Bank) Yoshihiro Kojima Masaaki Hirota May, 2025 Case Highlights NTT: Acquisition of NTT Data for JPY 2.37 trillion Minoru Sawaguchi Akira Matsushita Yohsuke Higashi Shimpei Ochi May, 2025 Management buyout of IMAGICA GROUP (represented the purchaser) Masakazu Kumagai Kensuke Sakajiri May, 2025 Case Highlights Japan Tobacco (JT): Sale of pharmaceutical business and Torii Pharmaceutical to Shionogi Hideki Ben Kazuhiro Kanamaru Taichi Arai Yusuke Takamiya Yurika Inoue Yuki Kawai Kohei Shiozaki Go back to Cases